Chandra Asri Pacific Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Chandra Asri Pacific Tbk. trades at Rp2,280 (market cap 194.65T, 160M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,620 (market cap 11.64T, 10.7K 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 16.7× Tempo Scan Pacific Tbk.'s market cap, and Chandra Asri Pacific Tbk. is more actively traded (160M versus 10.7K). Which is the better fit depends on your goals.
| TPIA | TSPC | |
|---|---|---|
Market Cap | 194.65T | 11.64T |
Volume | 160M | 10.7K |
Lot | 1.6M | 107 |
Turnover | 369.72B | 27.84M |
Average Price | 2,310.78 | 2,601.59 |
Value | 369.72B | 27.84M |
Indicative Equilibrium Price | 2,270 | 2,600 |
Indicative Equilibrium Volume | 31.27K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Read more on TPIA →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →